This topic contains a solution. Click here to go to the answer

Author Question: Why would the neurosurgeon not even consider a tube feeding until 72 hours post ... (Read 74 times)

javeds

  • Hero Member
  • *****
  • Posts: 570
Why would the neurosurgeon not even consider a tube feeding until 72 hours post injury?

Question 2

What do statins have to do with preventing atherosclerosis?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fauacakatahaias

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

ICP tends to continue to increase for about 72 hours post injury. During that time everything is done to try to keep down the CO2 level. Feeding would increase it.

Answer to Question 2

Statins, HMG-CoA reductase inhibitors, ompitively inhibit HMG-CoA reductase. This is the enzyme that catalyzes the early rate-limiting step in the synthesis of cholesterol; thus, it reduces total cholesterol, and LDL-C, and raises HDL-C. It also reduces triglycerides, VLDL, and apolipoprotein B.




javeds

  • Member
  • Posts: 570
Reply 2 on: Aug 2, 2018
Excellent


emsimon14

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library